Skandinaviska Enskilda Banken Ab (Publ) Krystal Biotech, Inc. Transaction History
Skandinaviska Enskilda Banken Ab (Publ)
- $20.7 Billion
- Q2 2024
A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 191,515 shares of KRYS stock, worth $33.9 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
191,515
Previous 217,747
12.05%
Holding current value
$33.9 Million
Previous $38.7 Million
9.22%
% of portfolio
0.17%
Previous 0.19%
Shares
12 transactions
Others Institutions Holding KRYS
# of Institutions
266Shares Held
25MCall Options Held
270KPut Options Held
172K-
Black Rock Inc. New York, NY3.95MShares$699 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.87MShares$508 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.43MShares$431 Million6.1% of portfolio
-
State Street Corp Boston, MA1.33MShares$236 Million0.01% of portfolio
-
Redmile Group, LLC San Francisco, CA1.02MShares$181 Million12.22% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $4.55B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...